HomeTagsAllied Disorders

Allied Disorders

Biotechnology

BioMarin Announces Oral Presentation of 2-Year Analysis of Largest Phase 3 Gene Therapy Study in Adults

PR Newswire - February 7, 2022

BioMarin Pharmaceutical Inc. announced that the Company presented positive results from a two-year analysis of the Phase 3 GENEr8-1 study and an overall safety...

Biotechnology

BioMarin Demonstrates Enduring Commitment to Advancing the Standard of Care in Hemophilia A

PR Newswire - February 3, 2022

BioMarin Pharmaceutical Inc. announced that the Company will be presenting data in several presentations on valoctocogene roxaparvovec, an investigational gene therapy for the treatment...